VEGFA and neoplasm: Interestingly, the Ang-2 blockade decreases angiogenesis and inhibits metastasis in mouse tumor models, while the Ang-2 blockade restrains tumor growth and decelerates tumor resistance to anti-VEGFA therapy in various types of cancer when administrated in combination with anti-VEGF drugs [35,40,41,42,43,44].